Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : LY3295668
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Recipient : Eli Lilly
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of AK-01 (LY3295668) in Solid Tumors
Details : LY3295668 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 28, 2017
Lead Product(s) : LY3295668
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Recipient : Eli Lilly
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
